RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

RAS isoforms are associated with the plasma membrane and endomembranes, but how their localization contributes to tumorigenesis is unclear. Here, the authors show that RAS signals from Golgi complex antagonize tumour formation by inducing apoptosis via ERK inhibition.

Guardado en:
Detalles Bibliográficos
Autores principales: Berta Casar, Andrew P. Badrock, Iñaki Jiménez, Imanol Arozarena, Paula Colón-Bolea, L. Francisco Lorenzo-Martín, Irene Barinaga-Rementería, Jorge Barriuso, Vincenzo Cappitelli, Daniel J. Donoghue, Xosé R. Bustelo, Adam Hurlstone, Piero Crespo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/1f3887098b28416d9c9f3a9d72788b25
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f3887098b28416d9c9f3a9d72788b25
record_format dspace
spelling oai:doaj.org-article:1f3887098b28416d9c9f3a9d72788b252021-12-02T15:34:06ZRAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation10.1038/s41467-018-05941-82041-1723https://doaj.org/article/1f3887098b28416d9c9f3a9d72788b252018-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05941-8https://doaj.org/toc/2041-1723RAS isoforms are associated with the plasma membrane and endomembranes, but how their localization contributes to tumorigenesis is unclear. Here, the authors show that RAS signals from Golgi complex antagonize tumour formation by inducing apoptosis via ERK inhibition.Berta CasarAndrew P. BadrockIñaki JiménezImanol ArozarenaPaula Colón-BoleaL. Francisco Lorenzo-MartínIrene Barinaga-RementeríaJorge BarriusoVincenzo CappitelliDaniel J. DonoghueXosé R. BusteloAdam HurlstonePiero CrespoNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-17 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Berta Casar
Andrew P. Badrock
Iñaki Jiménez
Imanol Arozarena
Paula Colón-Bolea
L. Francisco Lorenzo-Martín
Irene Barinaga-Rementería
Jorge Barriuso
Vincenzo Cappitelli
Daniel J. Donoghue
Xosé R. Bustelo
Adam Hurlstone
Piero Crespo
RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
description RAS isoforms are associated with the plasma membrane and endomembranes, but how their localization contributes to tumorigenesis is unclear. Here, the authors show that RAS signals from Golgi complex antagonize tumour formation by inducing apoptosis via ERK inhibition.
format article
author Berta Casar
Andrew P. Badrock
Iñaki Jiménez
Imanol Arozarena
Paula Colón-Bolea
L. Francisco Lorenzo-Martín
Irene Barinaga-Rementería
Jorge Barriuso
Vincenzo Cappitelli
Daniel J. Donoghue
Xosé R. Bustelo
Adam Hurlstone
Piero Crespo
author_facet Berta Casar
Andrew P. Badrock
Iñaki Jiménez
Imanol Arozarena
Paula Colón-Bolea
L. Francisco Lorenzo-Martín
Irene Barinaga-Rementería
Jorge Barriuso
Vincenzo Cappitelli
Daniel J. Donoghue
Xosé R. Bustelo
Adam Hurlstone
Piero Crespo
author_sort Berta Casar
title RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
title_short RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
title_full RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
title_fullStr RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
title_full_unstemmed RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation
title_sort ras at the golgi antagonizes malignant transformation through ptprκ-mediated inhibition of erk activation
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/1f3887098b28416d9c9f3a9d72788b25
work_keys_str_mv AT bertacasar rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT andrewpbadrock rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT inakijimenez rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT imanolarozarena rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT paulacolonbolea rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT lfranciscolorenzomartin rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT irenebarinagarementeria rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT jorgebarriuso rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT vincenzocappitelli rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT danieljdonoghue rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT xoserbustelo rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT adamhurlstone rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
AT pierocrespo rasatthegolgiantagonizesmalignanttransformationthroughptprkmediatedinhibitionoferkactivation
_version_ 1718386886311936000